Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-060-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05.Sept. 2012 - 22. Okt. 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: well documented guideline study under GLP
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- rel. humidity was between 65 - 95 % during pretest for several hours. However it does not affect the validity of the study.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- see above.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Initiator 94
- IUPAC Name:
- Initiator 94
- Test material form:
- other: liquid
- Details on test material:
- Name: Initiator 94
Batch: 004IN11
according to certificate of analysis and its addendum of 1. August 2012:
purity: 32% (main component and active species: benzpinakolsilylethers)
further composition: Phosphoric acid tributylester (Tributylphosphat) 19.3%, 1,2-Benzenedicarboxylic acid-di-2-propenylester (Diallylphthalate) 8.7%; Methylbenzene (toluol) 12.9%; Diphenylmethanone (Benzophenon) 12.4 %; 1,1,2,2-Tetraphenylethane-1,2-diol (Benzpinakol) 14.6%
density: 1.13 g/cm3 at 20°C
Production date of batch: 16.05.2011
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., Postbus 6174, NL-5960 AD Horst, The Netherlands
- Age at study initiation: pre-test: 11-12 weeks, main study: 9-10 weeks
- Housing: groupwise
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +- 2 °C
- Humidity (%): 45 - 65%
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- DMSO
- Concentration / amount:
- A solubility experiment was performed. The highest test item concentration, which could be technically used was a 10% suspension in dimethylsulfoxide (DMSO). At higher concentrations an applicable formulation of the test item was not achieved, neither by the use of other vehicles nor by using additional methods to formulate the test item, i.e. vortexing, sonicatin or warming to 37 °C.
To determine the highest non-irritant test concentration that at the same time did not sinduce signs of systemic toxicity, a pre-test was performed in two animals. Two mice were treated by a epidermal application to the dorsal surface of the ear one with a test item concentrations of 5 % and the other one with a test item concentration of 10 % once daily on three consecutive days.
On days 2-4 the animal treated with a test item concentration of 5 % developped a slight erythema of the skin of the ear.
The animal treated with 10 % developped a well defined erythema of the ears. On day 4 both animals had slightly scrabby ears. Thus the test item in the main study was assayed ar 2.5 %, 5 % and 10%. The highest concentration was the highest level that could be achieved with an applicable formulation and whilst avoiding systemic toxicity and excessive local skin irritation.
Challengeopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- DMSO
- Concentration / amount:
- A solubility experiment was performed. The highest test item concentration, which could be technically used was a 10% suspension in dimethylsulfoxide (DMSO). At higher concentrations an applicable formulation of the test item was not achieved, neither by the use of other vehicles nor by using additional methods to formulate the test item, i.e. vortexing, sonicatin or warming to 37 °C.
To determine the highest non-irritant test concentration that at the same time did not sinduce signs of systemic toxicity, a pre-test was performed in two animals. Two mice were treated by a epidermal application to the dorsal surface of the ear one with a test item concentrations of 5 % and the other one with a test item concentration of 10 % once daily on three consecutive days.
On days 2-4 the animal treated with a test item concentration of 5 % developped a slight erythema of the skin of the ear.
The animal treated with 10 % developped a well defined erythema of the ears. On day 4 both animals had slightly scrabby ears. Thus the test item in the main study was assayed ar 2.5 %, 5 % and 10%. The highest concentration was the highest level that could be achieved with an applicable formulation and whilst avoiding systemic toxicity and excessive local skin irritation.
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 3 consecutive days
- Test groups: 3
- Control group: 1
- Site: dorsal suface of the ear
- Frequency of applications: once daily
- Duration: 24 hours
- Concentrations: 0, 2.5%, 5% and 10% in 25µl/ear/day
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: five days after inuction exposure
- Exposure period: 5 hours
- Test groups:3
- Control group:1
- Site: injection into the tail vein
- Concentrations: 3H-methyl thymidine 19.7 µCi - Positive control substance(s):
- yes
Study design: in vivo (LLNA)
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- 0, 2.5%, 5%, 10%
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
A solubility experiment was performed. The highest test item concentration, which could be technically used was a 10% suspension in dimethylsulfoxide (DMSO). At higher concentrations an applicable formulation of the test item was not achieved, neither by the use of other vehicles nor by using additional methods to formulate the test item, i.e. vortexing, sonicatin or warming to 37 °C.
To determine the highest non-irritant test concentration that at the same time did not induce signs of systemic toxicity, a pre-test was performed in two animals. Two mice were treated by an epidermal application to the dorsal surface of the ear one with a test item concentration of 5 % and the other one with a test item concentration of 10 % once daily on three consecutive days.
On days 2-4 the animal treated with a test item concentration of 5 % developed a slight erythema of the skin of the ear.
The animal treated with 10 % developed a well defined erythema of the ears. On day 4 both animals had slightly scrabby ears. Thus the test item in the main study was assayed at 2.5 %, 5 % and 10%. The highest concentration was the highest level that could be achieved with an applicable formulation and whilst avoiding systemic toxicity and excessive local skin irritation.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: local lymphnode assay
- Criteria used to consider a positive response: Incorporation of 3H-methyl thymidine (3HTdR) at least 3-fold greater than in control mice and data should be compatible with a conventional dose response curve. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: 0 % 1.00 2.5 % 0.78 5 % 1.43 10% 2.24
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: 0 % 4871 2.5 % 3784 5 % 6965 10% 10907
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Conclusions:
- The test item Initiator 94 was not a skin sensitiser.
- Executive summary:
In the sudy the test item Initiator 94 was formulated in DMSO and assessed for its possible skin sensitising potential.
A local lymphnode assay was performed. Concentrations of the test item of 0 %, 2.5%, 5 % and 10 % in 25 µl DMSO/ear/day were applied to the dorsal surface of the ears of groups of 4 female mice. The highest concentration was the highest level that could be achieved with an applicable formulation and whilst avoiding systemic toxicity and excessive local skin irritation as shown by a pre-test.
The animals did not show any signs of systemic toxicity.
On days 2 -4 the animals treated with a test item concentration of 10 % showed an erythema of the ear. Animals treated with lower test item concentrations did not show any signs of local skin irritation.
Five days after the first application 19.7 µCi of 3HTdR were injected into the tail vein of each mouse. The limit of a more than 3 -fold greater incorporation of 3HTdR in the trated animals than in the concurrent controls is not reached. Therefore the test item is considered not to be a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.